Vaginal Slings Market Market Statistics - 2030
The global vaginal slings market size was valued at $1.1 billion in 2020, and is projected to reach $3.3 billion by 2030, growing at a CAGR of 12.4% from 2021 to 2030. Vaginal slings are incorporated in the surgical procedures used to treat stress urinary incontinence in women, using different types of vaginal slings, such as synthetic slings, natural slings, and single-incision slings. Stress urinary incontinence is a leakage of urine during moments of physical activity such as coughing, sneezing, laughing, or exercise, which increases abdominal pressure. It possesses a major effect on the quality of life and accounts for a large percentage of healthcare expenditures. Vaginal slings procedures are types of surgeries that help control stress urinary incontinence.
The key factors that drive the vaginal slings market share include rise in the incidence of stress urinary incontinence and increase in the female geriatric population. According to the Journal of BMC Geractric, in 2021, it was reported that around 70% of women above the age of 60 are diagnosed with incontinence disease. As per the same source, it was also reported that 45% of women below 60 years are diagnosed with urinary incontinence.
In addition, keen interest of market players in the development of materially advanced vaginal slings, increase the demand for vaginal slings industry, and surge the vaginal slings market growth. For instance, in 2021, Caldera Medical, a medical device company, announced the U.S Food and Drug Administration (FDA) clearance for new Desara TVez for stress urinary incontinence. Moreover, rise in demand for vaginal slings supplements for the treatment of urinary incontinence in women drives the growth of the vaginal slings industry. High emphasis on increasing public healthcare spending and strong focus on reducing maternal death cases are among the key factors fostering the growth of the vaginal slings market.
Furthermore, the changing lifestyle and demographic changes lead to increase in cases of gynecological problems in females at younger age. Moreover, increase in the number of hysterectomy cases, large number of women with early onset of menopause, and increase in obese population propel the market growth as women suffering from aforementioned health conditions are more susceptible to urinary incontinence. Post-operative complications of vaginal sling surgeries, such as infections, pelvic pain, adhesions, dyspareunia, and vulvar or vaginal disfigurement after vaginal surgery, and lack of awareness among women regarding the availability of vaginal slings are expected to restrict the market growth during the forecast period. This decreases the demand as well as adoption of vaginal slings in surgical treatment of urinary incontinence among women which hampers the market growth.
The initiative taken by government for the improvement in healthcare infrastructure and increase in the number of gynecological and urological centers cater the demand for vaginal sling procedures and drive the growth of the vaginal slings market share. In addition, high demand for single incision surgeries for incontinence management propels the growth of the market as patients prefer ambulatory surgical centers for single incision vaginal sling surgeries. Rise in disposable income and growth in demand for preventive measures against urinary incontinence present various opportunities for manufacturers of the vaginal slings market, where the technologically advanced vaginal sling product offers profitable opportunities for the expansion of the market. Moreover, increase in the number of hysterectomy cases, large number of women with early onset of menopause, and increase in obese population propel the market growth as women suffering from aforementioned health conditions are more susceptible to urinary incontinence.
Vaginal Slings Segmentation
The vaginal slings market is segmented into type, end user, and region. By type, the market is classified into conventional vaginal slings and advanced vaginal slings. On the basis of end user, it is classified into hospitals, clinics, and others.
Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By end users, the hospital segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to the large scale utilization of vaginal slings as well as increased preference of the geriatric population for surgical treatment of urinary incontinence in hospitals. However, the other end user segment is expected to witness considerable growth during the forecast period, due to increase in number of ambulatory surgical centers, individual doctor’s clinic, and gynecological centers to conduct surgeries for the treatment of incontinence issues in women. Increase in number of gynecological and urological centers cater the demand for vaginal sling procedures that contribute to high market growth for other end user segment.
Region-wise, North America dominated the vaginal slings market in 2020, and is expected to be dominant during the forecast period, owing to the early adoption of novel vaginal slings along with increase in prevalence of stress urinary incontinence among women in this region. However, Asia-Pacific is expected to register highest CAGR of 13.3% from 2021 to 2030, owing to high population base, growing disposable incomes, and rise in awareness among patient about advanced urinary incontinence management. The major companies profiled in this report include, A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Coloplast, Cousin Biotech, Caldera Medical, Medtronic PLC, Neomedic International, and Promedon Group.
Segment Review
Depending on type, the conventional vaginal slings segment was the highest contributor to the market in 2020, and this trend is expected to continue during the forecast period, due to high utilization of biomaterials, autologous cells, and allogenic cells in the development of vaginal slings.
However, the advance vaginal slings segment is expected to witness considerable growth during the vaginal slings market forecast period, owing to increase in demand for novel vaginal slings to reduce vaginal pain and internal bleeding.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vaginal slings market analysis from 2020 to 2030 to identify the prevailing vaginal slings market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the vaginal slings market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global vaginal slings market trends, key players, market segments, application areas, and market growth strategies.
Vaginal Slings Market Report Highlights
| Aspects | Details |
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | coloplast, Promedon Group, cousin biotech, B. BRAUN MELSUNGEN AG, neomedic international, Medtronic plc, Betatech Medical, Boston Scientific Corporation, Caldera Medical, A.M.I. GmbH |
Analyst Review
The utilization of vaginal slings for surgical treatment of urinary incontinence is expected to increase due to the increase in rate of stress incontinence experienced by women across the globe. Mid-urethral sling (MUS) procedures were considered to be the standard procedures for the treatment of female stress urinary incontinence (SUI). However, with increase in advancement in the vaginal slings, various market players are developing advanced vaginal slings. North America is projected to be the highest revenue contributor, whereas Asia-Pacific is expected to offer lucrative opportunities to the key players in this market.
Rise in the incidence of stress urinary incontinence coupled with increase in the female geriatric population, increase in the focus on development of materially advanced vaginal slings, and rise in the demand for single-incision vaginal slings are factors that mark the growth of the market. However, post-operative complications associated with the vaginal sling surgeries, and lack of awareness among patients regarding vaginal sling surgeries are anticipated to hamper the market growth. Several market players are focused toward developing vaginal slings that can be ideal for the incontinence management such as single incision slings, and tension free vaginal slings. Majority of manufacturers and distributors focus on expanding their presence in emerging economies.
The total market value of vaginal slings market is $1,074.8 million in 2020.
The forecast period in the report is from 2021 to 2030
The market value of vaginal slings market in 2021 was $1,149.7 million
The base year for the report is 2020.
Yes, vaginal slings companies are profiled in the report
The top companies that hold the market share in vaginal slings market are A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Coloplast, Cousin Biotech, Caldera Medical, Medtronic PLC, Neomedic International, and Promedon Group
The key trends in the vaginal slings market are rise in the incidence of stress urinary incontinence, increase in the female geriatric population, and keen interest of market players in the development of materially advanced vaginal slings
Loading Table Of Content...
